Clinical Trial Update: 4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial of a combination chemotherapy regimen for bladder cancer was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Bladder Cancer | Phase 3 | Status: TERMINATED | Results posted: 2017-06-08